Face-to-face with Abingworth's Stephen Bunting:we've had time to adapt to tough markets
This article was originally published in Scrip
Executive Summary
While many venture capital (VC) firms have dropped beneath the radar during the current credit squeeze, Abingworth is one of the few that is not just visible but appears to be operating on a business as usual basis. Scrip's biotechnology correspondent Sukaina Virji speaks to managing partner Stephen Bunting.